← 產業報告目錄
Insomnia Pharmacological Treatment Market Size, Share & Trends Analysis Report, By Drug (OTC Drugs, OTC Sleep Aids, OTC Sleep Supplements, Prescription Drugs), By Treatment (Over-the-Counter Sleep Aids, Prescription Sleep Aids), By Distribution Channel (Drug Stores, E-Commerce, Hospital Pharmacies, Retail Pharmacies), By Region, Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-17頁數 180報告編號 INSIGHTACE-17ba1dd485
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
With a 2024 valuation of USD 3.9 Billion, the global Insomnia Pharmacological Treatment Market is forecasted to increase to USD 7.3 Billion by 2034, demonstrating a CAGR of 6.6% during the 2025–2034 forecast window.
Insomnia Pharmacological Treatment covers reshaping how healthcare entities approach this space.
The market's upward path is fueled by expanding healthcare spending, technological evolution, and the expanding focus on personalized and precision-based approaches in healthcare.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, fueled by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Insomnia Pharmacological Treatment Market Snapshot
Chapter 4. Global Insomnia Pharmacological Treatment Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on Insomnia Pharmacological Treatment Market Industry Trends
4.10. Global Insomnia Pharmacological Treatment Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. Insomnia Pharmacological Treatment Market Segmentation 1: By Drug, Estimates & Trend Analysis
5.1. Market Share By Drug, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Product Type:
5.2.1. OTC Drugs
5.2.2. OTC Sleep Aids
5.2.3. OTC Sleep Supplements
5.2.4. Prescription Drugs
Chapter 6. Insomnia Pharmacological Treatment Market Segmentation 2: By Treatment, Estimates & Trend Analysis
6.1. Market Share By Treatment, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Source:
6.2.1. Over-the-Counter Sleep Aids
6.2.2. Prescription Sleep Aids
Chapter 7. Insomnia Pharmacological Treatment Market Segmentation 3: By Distribution Channel, Estimates & Trend Analysis
7.1. Market Share By Distribution Channel, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Distribution Channel:
7.2.1. Drug Stores
7.2.2. E-Commerce
7.2.3. Hospital Pharmacies
7.2.4. Retail Pharmacies
Chapter 8. Insomnia Pharmacological Treatment Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. Global Insomnia Pharmacological Treatment Market, Regional Snapshot 2024 & 2034
8.2. North America
8.2.1. North America Insomnia Pharmacological Treatment Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America Insomnia Pharmacological Treatment Market Revenue (US$ Million) Estimates and Forecasts By Drug, 2021-2034
8.2.3. North America Insomnia Pharmacological Treatment Market Revenue (US$ Million) Estimates and Forecasts By Treatment, 2021-2034
8.2.4. North America Insomnia Pharmacological Treatment Market Revenue (US$ Million) Estimates and Forecasts By Distribution Channel, 2021-2034
8.3. Europe
8.3.1. Europe Insomnia Pharmacological Treatment Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe Insomnia Pharmacological Treatment Market Revenue (US$ Million) Estimates and Forecasts By Drug, 2021-2034
8.3.3. Europe Insomnia Pharmacological Treatment Market Revenue (US$ Million) Estimates and Forecasts By Treatment, 2021-2034
8.3.4. Europe Insomnia Pharmacological Treatment Market Revenue (US$ Million) Estimates and Forecasts By Distribution Channel, 2021-2034
8.4. Asia Pacific
8.4.1. Asia Pacific Insomnia Pharmacological Treatment Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Southeast Asia
8.4.1.7. Rest of Asia Pacific
8.4.2. Asia Pacific Insomnia Pharmacological Treatment Market Revenue (US$ Million) Estimates and Forecasts By Drug, 2021-2034
8.4.3. Asia Pacific Insomnia Pharmacological Treatment Market Revenue (US$ Million) Estimates and Forecasts By Treatment, 2021-2034
8.4.4. Asia Pacific Insomnia Pharmacological Treatment Market Revenue (US$ Million) Estimates and Forecasts By Distribution Channel, 2021-2034
8.5. Latin America
8.5.1. Latin America Insomnia Pharmacological Treatment Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America Insomnia Pharmacological Treatment Market Revenue (US$ Million) Estimates and Forecasts By Drug, 2021-2034
8.5.3. Latin America Insomnia Pharmacological Treatment Market Revenue (US$ Million) Estimates and Forecasts By Treatment, 2021-2034
8.5.4. Latin America Insomnia Pharmacological Treatment Market Revenue (US$ Million) Estimates and Forecasts By Distribution Channel, 2021-2034
8.6. Middle East & Africa
8.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.6.1.1. GCC Countries
8.6.1.2. South Africa
8.6.1.3. Rest of Middle East and Africa
8.6.2. Middle East & Africa Insomnia Pharmacological Treatment Market Revenue (US$ Million) Estimates and Forecasts By Drug, 2021-2034
8.6.3. Middle East & Africa Insomnia Pharmacological Treatment Market Revenue (US$ Million) Estimates and Forecasts By Treatment, 2021-2034
8.6.4. Middle East & Africa Insomnia Pharmacological Treatment Market Revenue (US$ Million) Estimates and Forecasts By Distribution Channel, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Merck & Co Inc
9.2.1.1. Business Overview
9.2.1.2. Key Product Type/Service Overview
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. Ebb Therapeutics Inc/US
9.2.3. Pfizer Inc
9.2.4. Sanofi SA
9.2.5. Takeda Pharmaceutical Co Ltd
9.2.6. Paratek Pharmaceuticals Inc
9.2.7. Electromedical Products International Inc
9.2.8. Meda Pharmaceuticals Inc
9.2.9. Purdue Pharma LP
9.2.10. Pernix Therapeutics Holdings Inc
9.2.11. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們